Autonomix Med Inc.

13F holders, Q1 2026 (March 31)
15holders −2
2new positions
3sold out
$0.40avg. 13F price*

At the end of Q1 2026, 15 institutions reported holding Autonomix Med Inc. in their 13F filings, down 2 from Q4 2025. 2 opened new positions and 3 sold out. The largest holders were Geode Capital Management, LLC ($69K), Mariner, LLC ($26K) and UBS Group AG ($13K).

Company
Autonomix Med Inc.
CUSIP
05330T205
Latest filing quarter
Q1 2026

History

Number of 13F holders

05101520 Q4 2024: 14Q4 2024Q1 2025: 13Q1 2025Q2 2025: 20Q2 2025Q3 2025: 19Q3 2025Q4 2025: 17Q4 2025Q1 2026: 15Q1 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions2$5K
Exits3$6K

All 13F filers, Q4 2025 → Q1 2026: 198,378 shares bought and 11,176 shares sold, net +187,202 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 15 holders

Geode Capital Management, LLC 0.00% Add +647.1% 175,621 $69K
Mariner, LLC 0.00% Reduce -0.4% 52,910 $26K
UBS Group AG 0.00% Add +26275.6% 33,497 $13K
LPL Financial LLC 0.00% No change 31,435 $12K
Bank of Montreal 0.00% No change 25,000 $10K
Ikarian Capital, LLC 0.00% No change 18,688 $7K
Virtu Financial LLC 0.00% New 12,884 $5K
Tower Research Capital LLC (TRC) 0.00% Reduce -0.1% 5,841 $2K
PNC Financial Services Group, Inc. 0.00% No change 1,588 $619
Investors Research Corp 0.00% Reduce -9.1% 200 $78
Harbour Investments, Inc. 0.00% No change 10 $4
SWAN Capital LLC 0.00% No change 10 $4
Farther Finance Advisors, LLC 0.00% New 10 $4
Key Capital Management, INC 0.00% No change 10 $4
National Bank of Canada 0.00% No change 7 $3

"% of holder's portfolio" is AUTONOMIX MED INC's weight in each manager's 13F, not the share of Autonomix Med Inc. the manager owns.